Ama-hormone awahlali ethule. Kusukela emjikelezweni wokuqala wokuya esikhathini eminyakeni yobusha kuya ekushintsheni kwama-hormone okuya esikhathini emashumini eminyaka kamuva, umzimba wowesifazane uhlala ujwayela amazinga ashintshayo e-estrogen, i-progesterone, namanye ama-hormone. Isigaba ngasinye sokuphila siletha uhlobo lwaso "lokujwayelekile," kanye nezinselelo zaso.
Iminyaka Yokuzala: Isigqi Senyanga
Phakathi neminyaka yokuzala, umzimba wowesifazane usebenza ngomjikelezo wamahomoni othatha cishe inyanga yonke: i-estrogen iyanda engxenyeni yokuqala ukulungiselela umzimba ukukhulelwa okungenzeka, bese kuba yi-progesterone ethatha indawo ngemva kokukhishwa kweqanda. Uma lesi sigqi siphazanyiswa, kungaba yizimpawu zansuku zonke zangaphambi kokuya esikhathini noma ukungalingani okukhulu kwamahomoni njenge-polycystic ovary syndrome (PCOS), imiphumela ekuhambisaneni komjikelezo, isikhumba, kanye nenduduzo yansuku zonke ingaba nkulu.
Isikhathi Sokunqamuka Kokuya Emuva Nokuya Emuva: Isisekelo Esishintshayo
Isikhathi sokuphela kokuya esikhathini, isikhathi sokuguquka ngaphambi kokuba ukuya esikhathini kuphele ngokuphelele, sivame ukuqala kwabesifazane abaneminyaka engu-40. Amazinga e-estrogen ne-progesterone awanciphi kancane kancane phakathi nalesi sigaba, ayashintshashintsha, ngezinye izikhathi kakhulu, okuyikho okwenza ukuya esikhathini, ubuthongo, kanye nesimo sengqondo kuzwakale kungalindelekile phakathi nalesi sikhathi. Ukuya esikhathini ngokwako kufinyelelwa ngemva kwezinyanga eziyishumi nambili ezilandelanayo ngaphandle kokuya esikhathini, okuphawula isigaba esizinzile nesiphansi se-estrogen, yize ukushintshela lapho kuvame ukuba yikona okubangela izimpawu eziphawuleka kakhulu: ukushisa okukhulu, ukujuluka ebusuku, kanye nokuphazamiseka kokulala.
Lokho Okushiwo Ucwaningo Lwezitshalo
Kuye kwafundwa izithasiselo eziningana zezitshalo ngendima yazo ekusekeleni abesifazane ngalezi zinguquko zamahomoni. I-Ashwagandha ( Withania somnifera ), isibonelo, ihlolwe ikakhulukazi kwabesifazane abaseminyakeni yokuthomba: esivivinyweni samasonto ayisishiyagalombili sabesifazane abayi-100, labo abathatha ama-300 mg we-ashwagandha root extract kabili ngosuku babone ukuthuthuka okukhulu kakhulu emazingeni ezimpawu zokuthomba kuneqembu le-placebo, kanye nokwanda okulinganiselwe kwe-estradiol kanye nokwehla kwe-FSH kanye ne-LH (Gopal et al., 2021). I-Shatavari ( Asparagus racemosus ), okwamanje, inomlando omude kwezokwelapha ze-Ayurvedic ezihlotshaniswa ngqo nempilo yabesifazane, ngenxa yama-steroidal saponins empandeni yawo afundelwa umsebenzi omnene, ofana ne-phytoestrogen. Zombili ziyizithasiselo zezitshalo i-NaturMed Scientific inikeza ngendlela ejwayelekile.
USerebelle: Lokho Okuboniswa Yidatha Yezokwelapha
I-Serebelle iyi-NaturMed Scientific's standardized Shatavari root extract, futhi ngokungafani nezithako eziningi zezitshalo kulesi sikhala, ihlolwe ezivivinyweni ezimbili ezihlukene, ezibhalisiwe, ezingahleliwe, ezingaboni kabili, ezilawulwa yi-placebo, ngayinye ihlose isigaba sokuphila esihlukile.
Kwabesifazane abaneminyaka engu-20-35 abanokungalingani kwama-hormone okuhlobene ne-PCOS (n=60, izinsuku ezingu-84), i-Serebelle yenze umehluko omkhulu uma iqhathaniswa ne-placebo. Umthamo wama-ovari wehle ngo-21%, usayizi wama-cyst wehla ngo-41%, kanti inani lama-follicle lehle ngo-21% (p<0.0001). Ekupheleni kocwaningo, ama-62% abesifazane abathatha i-Serebelle babenomthamo wama-ovari emuva ebangeni elinempilo, uma kuqhathaniswa nama-7% kuphela ku-placebo. Ukuzwela kwe-insulin kuthuthukile, amazinga e-testosterone ehla, kanti i-hormone ebizwa nge-SHBG yakhuphuka, konke kungcono kune-placebo. I-Hirsutism kanye ne-acne scores nazo zathuthuka (Kondamudi et al., 2025).
Kwabesifazane abaseminyakeni yokuqala yokuthomba abaneminyaka engu-40-50 (n=75, izinsuku ezingu-120), imithamo yansuku zonke engu-50 mg kanye nengu-100 mg ye-Serebelle yehlisa amaphuzu ezimpawu zokuthomba ngamaphesenti angu-51-73, uma kuqhathaniswa nokuthuthuka okungu-23% kuphela ku-placebo (p<0.001). Ukushisa kwancipha ngamaphesenti afinyelela ku-40% kumthamo ophezulu, kuyilapho kwaba kubi kancane eqenjini le-placebo. I-FSH, i-hormone ekhuphukayo njengoba ukuthomba kusondela, yehle ngamaphesenti afinyelela ku-61, kanti i-LH yehle ngamaphesenti afinyelela ku-43%. I-AMH, uphawu lwe-ovarian reserve, yenyuke ngamaphesenti afinyelela ku-270 kumthamo ophezulu. Zonke lezi zinguquko zazingcono kakhulu kunezindawo zokuqala kanye ne-placebo (p<0.001) (Yadav et al., 2025).
Kuzo zombili izivivinyo, iSerebelle yayibekezelelwe kahle, kungekho zenzakalo ezimbi ezibikiwe. Zombili lezi zifundo zixhaswe yiChemiloids Life Sciences, okufanele kuqashelwe ukuze kube sobala; ukukopisha ngokuzimela kuzokwengeza ukuzethemba okwengeziwe kule miphumela.
Izixwayiso Ezimbalwa Ezithembekile
Ucwaningo lwezitshalo kulesi sigaba lusakhula. Izimpawu zama-hormone zingaphinde zihlangane nezinye izimo zempilo, njengezinkinga ze-thyroid, ngakho-ke noma ubani obhekene nezimpawu ezibalulekile noma eziqhubekayo kufanele akhulume nomhlinzeki wezempilo ngaphambi kokuqala noma yisiphi isithasiselo esisha, ikakhulukazi ngesikhathi sokukhulelwa noma ngenkathi encelisa. Lokho ucwaningo olukubonisayo kuze kube manje kuyakhuthaza ngempela, kodwa kufanele kufundwe njengengxenye yendlela ebanzi, eyenzelwe wena uqobo empilweni yabesifazane.
Qaphela: Izithako okuxoxwe ngazo kulesi sihloko ziyizithako zokudla, hhayi imikhiqizo yezokwelapha enelayisensi, futhi azihloselwe ukuxilonga, ukwelapha, ukwelapha, noma ukuvimbela noma yisiphi isifo. Abathengi abanezinkinga zempilo ezikhona noma labo abathatha imithi bayelulekwa ukuthi babonisane nochwepheshe wezempilo oqeqeshiwe ngaphambi kokusebenzisa.
Okubhekwayo
UGopal, S., u-Ajgaonkar, A., uKanchi, P., uKaundinya, A., uThakare, V., uChauhan, S. noLangade, D. (2021) 'Umphumela we-ashwagandha (Withania somnifera) impande ezimpawu ze-climacteric kwabesifazane ngesikhathi sokuya esikhathini: ucwaningo olungahleliwe, olungaboni kabili, olulawulwa yi-placebo', i-Journal of Obstetrics and Gynaecology Research, 47(12), amakhasi 4414–4425. Itholakala ku: https://doi.org/10.1111/jog.15030
UKandamudi, S., uSadu, S., uDeva, S., uYalamanchi, A. kanye noYalamanchi, A. (2025) 'I-CL22209, i-Asparagus racemosus root extract standardized, ikhombisa ukwakheka kwe-ovarian okuthuthukisiwe, ukujwayela kokuya esikhathini, kanye nemingcele ye-metabolic kwabesifazane abane-polycystic ovary syndrome esivivinyweni esingahleliwe, esilawulwayo', i-Food & Nutrition Research, 69, isihloko 13244. Itholakala ku: https://doi.org/10.29219/fnr.v69.13244
Yadav, P., Yadav, S., Vedururu, SS kanye noKumari, G. (2025) 'Ukuhlolwa komtholampilo kwe-CL22209, isiqeshana esijwayelekile se-Asparagus racemosus, sokunciphisa izimpawu ze-vasomotor kanye nokuya esikhathini kwabesifazane abaseminyakeni yokuthomba: ucwaningo olungahleliwe, olungaboni kabili, olulawulwa yi-placebo', Functional Foods in Health and Disease, 15(7), amakhasi 415–443. Kutholakala ku: https://doi.org/10.31989/ffhd.v15i7.1684
Isixwayiso: Lesi Sitatimende asikahlolwa yi-EFSA, i-KFDA noma i-FDA. Lo mkhiqizo awuhloselwe ukuxilonga, ukwelapha, ukwelapha, noma ukuvimbela noma yisiphi isifo. Nakuba ulwazi olunikeziwe lusekelwe ezinkombeni ezithembekile, asenzi noma yiziphi izimangalo noma iziqinisekiso ezithile. Kubalulekile ukubonisana nomeluleki wakho wezempilo ukuze uthole iseluleko nesiqondiso esiqondene nawe esiphathelene nempilo yakho.
